By using the Volpara website you accept our use of cookies. Here’s our privacy statement.
Breast Health
Lung Health


Volpara has acquired breast cancer risk assessment company CRA Health, LLC. Volpara Risk™ is now a complete program for identifying and managing high-risk patients. Together we'll apply world-class knowledge about risk and genetics to prevent advanced-stage breast cancer.

15 year

Focus on breast cancer risk assessment

2 m+

Breast cancer risk assessments performed annually


With major Electronic Health Records and genetic testing companies

Ask the Right Questions

Assess patient risk immediately

Digital surveys completed by the patient at home or in the clinic to determine if genetic testing or additional imaging is appropriate.

Align Risk Models & Guidelines

Find the right fit for your priorities

A complete picture of a patient’s breast cancer risk and breast screening pathways.

More Informed Decisions

The right message in the right method

Create educational or medical necessity communications for patients, physicians, and payers to advocate for and better coordinate care.

Follow Progress & Outcomes

Keep focused on the patient throughout the breast screening journey

Convenient, easy-to-use system tracks patient progress, updates risk profiles, generates communication, and triggers follow-up.

Try a demonstration of our risk tools

Interested? Request a demo or consultation.


You might be interested in...

Breast Cancer Risk assessment
25 Nov 2019

Guide to Best Practices for Clinical Tyrer-Cuzick Risk Assessment

Volpara Health & CRA Health
1 Feb 2021

Volpara Acquires Breast Cancer Risk Assessment Company CRA Health, LLC.